Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that their Tapestri® platform can profile vector copy number (VCN), surface protein ...
Donor availability and transplantation-related risks limit the broad use of allogeneic hematopoietic-cell transplantation in patients with transfusion-dependent β-thalassemia. After previously ...
SOUTH SAN FRANCISCO, Calif., April 30, 2026--(BUSINESS WIRE)--Mission Bio, the leader in single-cell multiomics, published research in Molecular Therapy Advances showing that their Tapestri® platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results